Mimedx Group Inc (NASDAQ: MDXG)’s stock price has dropped by -6.54 in relation to previous closing price of 6.88. Nevertheless, the company has seen a loss of -5.44% in its stock price over the last five trading days. seekingalpha.com reported 2025-04-30 that MiMedx Group, Inc. (NASDAQ:MDXG ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Matthew Notarianni – Head, IR Joseph Capper – CEO & Director Doug Rice – CFO Conference Call Participants Carl Byrnes – Northland Capital Markets Chase Knickerbocker – Craig-Hallum Capital Group Ross Osborn – Cantor Fitzgerald Anthony Petrone – Mizuho Group Operator Good afternoon, and thank you for standing by. Welcome to the MIMEDX First Quarter 2025 Operating and Financial Results Conference Call.
Is It Worth Investing in Mimedx Group Inc (NASDAQ: MDXG) Right Now?
Mimedx Group Inc (NASDAQ: MDXG) has a higher price-to-earnings ratio of 22.60x compared to its average ratio. MDXG has 36-month beta value of 1.85. Analysts have mixed views on the stock, with 5 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for MDXG is 115.91M, and currently, short sellers hold a 4.17% ratio of that float. The average trading volume of MDXG on May 01, 2025 was 551.31K shares.
MDXG’s Market Performance
MDXG stock saw a decrease of -5.44% in the past week, with a monthly decline of -14.27% and a quarterly a decrease of -27.83%. The volatility ratio for the week is 3.70%, and the volatility levels for the last 30 days are 4.60% for Mimedx Group Inc (MDXG). The simple moving average for the past 20 days is -6.01% for MDXG’s stock, with a -14.66% simple moving average for the past 200 days.
Analysts’ Opinion of MDXG
Many brokerage firms have already submitted their reports for MDXG stocks, with Cantor Fitzgerald repeating the rating for MDXG by listing it as a “Overweight.” The predicted price for MDXG in the upcoming period, according to Cantor Fitzgerald is $11 based on the research report published on July 02, 2024 of the previous year 2024.
Lake Street, on the other hand, stated in their research note that they expect to see MDXG reach a price target of $12. The rating they have provided for MDXG stocks is “Buy” according to the report published on March 07th, 2024.
Craig Hallum gave a rating of “Buy” to MDXG, setting the target price at $12 in the report published on October 27th of the previous year.
MDXG Trading at -14.26% from the 50-Day Moving Average
After a stumble in the market that brought MDXG to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -36.59% of loss for the given period.
Volatility was left at 4.60%, however, over the last 30 days, the volatility rate increased by 3.70%, as shares sank -14.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.80% lower at present.
During the last 5 trading sessions, MDXG fell by -3.75%, which changed the moving average for the period of 200-days by -8.20% in comparison to the 20-day moving average, which settled at $6.85. In addition, Mimedx Group Inc saw -33.16% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MDXG starting from Maersk-Moller Kimberly, who sale 1,759 shares at the price of $8.04 back on Mar 17 ’25. After this action, Maersk-Moller Kimberly now owns 309,077 shares of Mimedx Group Inc, valued at $14,142 using the latest closing price.
Hulse William Frank IV, the General Counsel and CAO of Mimedx Group Inc, sale 54,596 shares at $7.89 during a trade that took place back on Mar 13 ’25, which means that Hulse William Frank IV is holding 440,178 shares at $430,762 based on the most recent closing price.
Stock Fundamentals for MDXG
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.82 for the gross margin
The net margin for Mimedx Group Inc stands at 0.11. The total capital return value is set at 0.24. Equity return is now at value 25.01, with 16.70 for asset returns.
Based on Mimedx Group Inc (MDXG), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 60.05. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 105.93.
Currently, EBITDA for the company is 64.34 million with net debt to EBITDA at -1.92. When we switch over and look at the enterprise to sales, we see a ratio of 2.34. The receivables turnover for the company is 5.66for trailing twelve months and the total asset turnover is 1.3. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.21.
Conclusion
To put it simply, Mimedx Group Inc (MDXG) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
